LSE - Delayed Quote NOK

Aqua Bio Technology ASA (0I8C.L)

1.1440
+0.0440
+(4.00%)
At close: May 28 at 3:48:52 PM GMT+1
Loading Chart for 0I8C.L
  • Previous Close 1.1000
  • Open 1.0120
  • Bid --
  • Ask --
  • Day's Range 1.0120 - 1.3500
  • 52 Week Range 1.0120 - 4.6496
  • Volume 232,398
  • Avg. Volume 1,900
  • Market Cap (intraday) --
  • Beta (5Y Monthly) 0.79
  • PE Ratio (TTM) --
  • EPS (TTM) -0.9850
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Aqua Bio Technology ASA engages in the manufacture and sale of ingredients for cosmetic industry in Norway. It offers Aquabeautine XL, a proprietary ingredient for skincare products; and Spirulysat, an antioxidant and vitamin-boosted spirulina for cosmetic use. The company distributes its products through Internet, stores, and skincare clinics. Aqua Bio Technology ASA was founded in 2000 and is based in Oslo, Norway.

aquabiotechnology.com

36

Full Time Employees

December 31

Fiscal Year Ends

--

Sector

--

Industry

Recent News: 0I8C.L

Más detalles

Performance Overview: 0I8C.L

Trailing total returns as of 5/29/2025, which may include dividends or other distributions. Benchmark is MSCI WORLD (^990100-USD-STRD) .

YTD Return

0I8C.L
0.00%
MSCI WORLD (^990100-USD-STRD)
3.69%

1-Year Return

0I8C.L
0.00%
MSCI WORLD (^990100-USD-STRD)
12.09%

3-Year Return

0I8C.L
75.40%
MSCI WORLD (^990100-USD-STRD)
0.00%

5-Year Return

0I8C.L
75.40%
MSCI WORLD (^990100-USD-STRD)
78.99%

Comparar con: 0I8C.L

Puedes seleccionar hasta 4 acciones para analizar empresas similares utilizando métricas clave de rendimiento.

Statistics: 0I8C.L

Más detalles

Valuation Measures

Annual
As of
  • Market Cap

    --

  • Enterprise Value

    --

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -31.51%

  • Return on Equity (ttm)

    -16,707.20%

  • Revenue (ttm)

    107.17M

  • Net Income Avi to Common (ttm)

    -337.35M

  • Diluted EPS (ttm)

    -0.9850

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    17.19M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -51.78M

Research Analysis: 0I8C.L

Más detalles

Company Insights: 0I8C.L

Reportes de investigación: 0I8C.L

Más detalles

People Also Watch